137 related articles for article (PubMed ID: 1378984)
41. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis.
Jahkola T; Toivonen T; von Smitten K; Blomqvist C; Virtanen I
Int J Cancer; 1996 Dec; 69(6):445-7. PubMed ID: 8980244
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease.
Jaskiewicz K; Chasen MR; Robson SC
Anticancer Res; 1993; 13(6A):2229-37. PubMed ID: 8297138
[TBL] [Abstract][Full Text] [Related]
43. Tenascin immunoreactivity in normal and pathological bone marrow.
Soini Y; Kamel D; Apaja-Sarkkinen M; Virtanen I; Lehto VP
J Clin Pathol; 1993 Mar; 46(3):218-21. PubMed ID: 7681854
[TBL] [Abstract][Full Text] [Related]
44. [Immunohistochemical study of oncogene c-erbb-2 expression and extracellular matrix proteins in breast cancer (various mechanisms of invasion)].
Pozharisskiĭi KM; Kyshtoobaeva ASh; Turkevich EA
Arkh Patol; 1997; 59(4):19-25. PubMed ID: 9334150
[TBL] [Abstract][Full Text] [Related]
45. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
Moinfar F; Okcu M; Tsybrovskyy O; Regitnig P; Lax SF; Weybora W; Ratschek M; Tavassoli FA; Denk H
Cancer; 2003 Aug; 98(4):703-11. PubMed ID: 12910513
[TBL] [Abstract][Full Text] [Related]
46. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications.
Koukoulis GK; Gould VE; Bhattacharyya A; Gould JE; Howeedy AA; Virtanen I
Hum Pathol; 1991 Jul; 22(7):636-43. PubMed ID: 1712747
[No Abstract] [Full Text] [Related]
47. Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma.
Sugawara I; Hirakoshi J; Kusakabe M; Masunaga A; Itoyama S; Sakakura T
Jpn J Cancer Res; 1993 Jul; 84(7):703-7. PubMed ID: 7690353
[TBL] [Abstract][Full Text] [Related]
48. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia.
Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM
Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930
[TBL] [Abstract][Full Text] [Related]
49. Tenascin expression in basal cell carcinoma.
Verstraeten AA; Mackie EJ; Hageman PC; Hilgers J; Schol DJ; De Jongh GJ; Schalkwijk J
Br J Dermatol; 1992 Dec; 127(6):571-4. PubMed ID: 1282358
[TBL] [Abstract][Full Text] [Related]
50. The high-molecular-weight J1 glycoproteins are immunochemically related to tenascin.
Faissner A; Kruse J; Chiquet-Ehrismann R; Mackie E
Differentiation; 1988; 37(2):104-14. PubMed ID: 2456237
[TBL] [Abstract][Full Text] [Related]
51. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
[TBL] [Abstract][Full Text] [Related]
52. Lobular carcinoma of the breast an ultrastructural comparison with certain duct carcinomas and benign lesions.
Carter D; Yardley JH; Shelley WM
Johns Hopkins Med J; 1969 Jul; 125(1):25-32. PubMed ID: 4186130
[No Abstract] [Full Text] [Related]
53. Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma.
Ibrahim SN; Lightner VA; Ventimiglia JB; Ibrahim GK; Walther PJ; Bigner DD; Humphrey PA
Hum Pathol; 1993 Sep; 24(9):982-9. PubMed ID: 7504654
[TBL] [Abstract][Full Text] [Related]
54. Expression of tenascin in developing and adult mouse lymphoid organs.
Ocklind G; Talts J; Fässler R; Mattsson A; Ekblom P
J Histochem Cytochem; 1993 Aug; 41(8):1163-9. PubMed ID: 7687262
[TBL] [Abstract][Full Text] [Related]
55. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues.
Natali PG; Nicotra MR; Bigotti A; Botti C; Castellani P; Risso AM; Zardi L
Int J Cancer; 1991 Apr; 47(6):811-6. PubMed ID: 1707033
[TBL] [Abstract][Full Text] [Related]
56. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential.
Harada T; Shinohara M; Nakamura S; Oka M
Virchows Arch; 1994; 424(3):257-66. PubMed ID: 7514477
[TBL] [Abstract][Full Text] [Related]
57. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.
Tiitta O; Wahlström T; Paavonen J; Linnala A; Sharma S; Gould VE; Virtanen I
Am J Pathol; 1992 Oct; 141(4):907-13. PubMed ID: 1384340
[TBL] [Abstract][Full Text] [Related]
58. Specific expression of tenascin in human colonic neoplasms.
Sakai T; Kawakatsu H; Hirota N; Yokoyama T; Sakakura T; Saito M
Br J Cancer; 1993 May; 67(5):1058-64. PubMed ID: 7684238
[TBL] [Abstract][Full Text] [Related]
59. Localization and cellular source of the extracellular matrix protein tenascin in normal and fibrotic rat liver.
Van Eyken P; Geerts A; De Bleser P; Lazou JM; Vrijsen R; Sciot R; Wisse E; Desmet VJ
Hepatology; 1992 May; 15(5):909-16. PubMed ID: 1373703
[TBL] [Abstract][Full Text] [Related]
60. Tenascin expression and postnatal development of the human prostate.
Shiraishi T; Kato H; Komada S; Imai H; Hirokawa Y; Kusano I; Yatani R; Sakakura T
Int J Dev Biol; 1994 Jun; 38(2):391-5. PubMed ID: 7526883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
